why choose us

Course: Access to COVID-19 Vaccines in High-, Middle-, and Low-Income Countries Hosting Clinical Trials

CME Credits: 1.00

Released: 2021-11-18

The COVID-19 pandemic has led to the rapid development of multiple vaccines, tested in clinical trials located in several countries. Low- and middle-income countries have experienced significant delays in vaccine access despite initiatives aiming to ensure fair distribution, such as COVID-19 Vaccines Global Access (COVAX). Because pharmaceuticals do not receive consistent and timely authorization for use in lower-income countries where they are tested, we examined authorization and delivery of COVID-19 vaccines recommended by the World Health Organization (WHO) in the countries where they were tested.


Educational Objective
To identify the key insights or developments described in this article


View Full Course